These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2818622)

  • 1. Desferrithiocin and desferrioxamine B. Cellular pharmacology and storage iron mobilization.
    Jin Y; Baquet A; Florence A; Crichton RR; Schneider YJ
    Biochem Pharmacol; 1989 Oct; 38(19):3233-40. PubMed ID: 2818622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
    Kicic A; Chua AC; Baker E
    Br J Pharmacol; 2002 Mar; 135(6):1393-402. PubMed ID: 11906952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization.
    Laub R; Schneider YJ; Octave JN; Trouet A; Crichton RR
    Biochem Pharmacol; 1985 Apr; 34(8):1175-83. PubMed ID: 3994740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.
    Octave JN; Schneider YJ; Crichton RR; Trouet A
    Biochem Pharmacol; 1983 Nov; 32(22):3413-8. PubMed ID: 6651865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes.
    Waterkeyn C; Laduron P; Meuldermans W; Trouet A; Schneider YJ
    Biochem Pharmacol; 1987 Dec; 36(23):4129-36. PubMed ID: 3120732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
    Longueville A; Crichton RR
    Biochem Pharmacol; 1986 Nov; 35(21):3669-78. PubMed ID: 3778498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat.
    Dexter DT; Ward RJ; Florence A; Jenner P; Crichton RR
    Biochem Pharmacol; 1999 Jul; 58(1):151-5. PubMed ID: 10403528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of transferrin protein and iron in the perfused rat liver. Effect of Triton WR 1339, digitonin and temperature.
    Sibille JC; Octave JN; Schneider YJ; Trouet A; Crichton R
    Eur J Biochem; 1986 Feb; 155(1):47-55. PubMed ID: 3948880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP; Porter JB
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
    Baker E; Wong A; Peter H; Jacobs A
    Br J Haematol; 1992 Jul; 81(3):424-31. PubMed ID: 1340769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents.
    Kicic A; Chua AC; Baker E
    Anticancer Drug Des; 2001; 16(4-5):195-207. PubMed ID: 12049478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tridentate iron chelators: from desferrithiocin to ICL670.
    Nick H; Acklin P; Lattmann R; Buehlmayer P; Hauffe S; Schupp J; Alberti D
    Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E; Vitolo ML; Webb J
    Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
    Bergeron RJ; Streiff RR; Creary EA; Daniels RD; King W; Luchetta G; Wiegand J; Moerker T; Peter HH
    Blood; 1993 Apr; 81(8):2166-73. PubMed ID: 8471775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox.
    Rakba N; Aouad F; Henry C; Caris C; Morel I; Baret P; Pierre JL; Brissot P; Ward RJ; Lescoat G; Crichton RR
    Biochem Pharmacol; 1998 Jun; 55(11):1797-806. PubMed ID: 9714298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    Stahel E; Mazier D; Guillouzo A; Miltgen F; Landau I; Mellouk S; Beaudoin RL; Langlois P; Gentilini M
    Am J Trop Med Hyg; 1988 Sep; 39(3):236-40. PubMed ID: 3052118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus.
    de Locht M; Boelaert JR; Schneider YJ
    Biochem Pharmacol; 1994 May; 47(10):1843-50. PubMed ID: 8204101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin and iron release from rat hepatocytes in culture.
    Baker E; Page M; Morgan EH
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G93-7. PubMed ID: 3966565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.